Business Context and Reporting Period
Company: Trio-Tech International
Filing Type: Form 10-K (Annual Report)
Period Ended: June 27, 1997
Business Overview: The Company designs, manufactures, and markets environmental testing equipment for semiconductor devices and operates testing facilities globally. Key operations include manufacturing in the U.S., Ireland, and Singapore; testing services in the U.S., Southeast Asia, and Europe; and distribution activities primarily in Singapore. The Company serves high-reliability markets including aerospace, military, and commercial semiconductor manufacturers.
Key Financial Metrics
| Metric (in thousands) | Fiscal 1997 | Fiscal 1996 |
|---|---|---|
| Net Sales | $21,548 | $23,185 |
| Gross Profit | $8,830 | $8,520 |
| Income from Operations | $3,057 | $2,712 |
| Net Income | $1,002 | $806 |
| Net Income Per Share (Primary) | $0.77 | $0.63 |
| Working Capital | $6,804 | $3,591 |
| Total Assets | $18,528 | $17,416 |
| Long-Term Debt | $723 | $688 |
| Cash and Cash Deposits | $7,972 | $5,228 |
Margins: Gross margin improved to 41.0% in 1997 from 36.8% in 1996. Operating margin was 14.2% in 1997 compared to 11.7% in 1996.
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 7.1% to $21.5 million, primarily due to a general slowdown in the semiconductor industry and lower testing volumes in Singapore and Malaysia.
- Profitability Increase: Despite lower sales, Net Income increased 24.3% to $1.0 million. This was driven by a significant reduction in Cost of Sales (down 13.3%) due to stringent cost controls and scaled-down operations in the Far East.
- Segment Performance: The Testing Services segment remained the primary revenue driver (56% of sales). The Manufacturing segment reported an operating loss of $881,000 in 1997, widening from a $367,000 loss in 1996. The Distribution segment turned a small profit of $20,000 after a $363,000 loss in the prior year.
- Liquidity Improvement: Working capital increased significantly from $3.6 million to $6.8 million, supported by improved cash collections and profitability.
Outlook, Risks, and Contingencies
- Backlog: Total backlog increased to $5.86 million (from $4.62 million), with manufacturing and testing services scheduled for delivery within 12 months. Management does not anticipate significant cancellations.
- Legal Contingency: The Company is a defendant in a civil action regarding soil and groundwater contamination at the North Hollywood Superfund Site. Management believes liability insurance should cover the claim and does not expect a material impact on financial position, though insurers have not yet made a final decision.
- Forward-Looking Risks: Risks include market acceptance of products, changing semiconductor industry conditions, competition, international business risks (currency fluctuations, political instability), and potential difficulties in obtaining specific raw materials (Fluorinert, Krypton 85).
- Capital Resources: The Company maintains several lines of credit totaling approximately $1.0 million. Borrowings under these lines were minimal as of year-end, with a revolving line of $150,000 fully utilized.
Investor Verification Checklist
- Customer Concentration: Verify the stability of the two major customers who accounted for 35% of total sales (13% and 22%) in fiscal 1997.
- Manufacturing Segment Loss: Investigate the widening operating loss in the Manufacturing segment ($881k) despite overall company profitability.
- Foreign Currency Exposure: Assess the impact of currency fluctuations on the significant portion of assets and operations located in Southeast Asia (Malaysia, Singapore, Thailand).
- Superfund Litigation: Monitor the status of the insurance claim regarding the North Hollywood contamination lawsuit.
- Stock Split: Note the Board's approval of a 3-for-2 stock split in July 1997; verify the impact on share count and per-share metrics in subsequent filings.